Connect with us

Femtech World Awards

Menopause innovation to take centre stage at Femtech World Awards



The innovations helping women navigate and better understand menopause are to be recognised in the first-ever Femtech World Awards. 

The inaugural Femtech World Awards will shine a spotlight on the organisations driving innovation in women’s health.

The Menopause Innovation award will give recognition to those working in the menopause sector whose work and dedication are shaping the future of healthcare.

Sponsored by the AI fertility company Fairtility, the award is one of 10 categories open for entry in the Femtech World Awards, which seek to support the next wave of innovation in women’s health and recognise the outstanding commitment to improving patient outcomes.

Fairtility is advancing reproductive care through the power of transparent AI to help clinicians and their patients on the reproductive care journey.

The company believes that transparency is critical when AI intersects with human life. Its flagship software, CHLOE, is a transparent AI-based decision support tool providing clinicians with visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation and egg donation.

Eran Eshed, co-founder and CEO of Fairtility, said: “Fairtility is honoured to be part of the Menopause Innovation award, recognising the need for progressive solutions in women’s health.

“Menopause affects half of the population, yet the conversation surrounding it is often shrouded in misconceptions. By sponsoring this category, we aim to support groundbreaking innovations that will contribute to a brighter, more informed future for women worldwide.”

Sorina Mihaila, editor of Femtech World, said: “Although virtually all women experience menopause, it remains a highly stigmatised topic.

“Our aim is to tackle some of that stigma by celebrating the life-changing innovations in this space.”

Find out more about the awards and enter for free here.

Femtech World Awards

Four inspirational leaders shortlisted for Femtech World award



Four inspirational leaders have been shortlisted for the Femtech World Leader of the Year award, sponsored by IVF 2.0.

IVF2.0 is a UK-based company which uses AI to improve IVF outcomes. Its tools help embryologists better select oocytes, embryos and sperm to ease workload and increase pregnancy success rates.

The company has a strong research background, peer reviewed publications and experienced leadership.

The team will judge the four submissions for the Leader of the Year category, with the winner announced at a virtual ceremony on May 2.

Congratulations to the shortlist for making the cut and many thanks to all the other submissions for taking the time to enter.

Inessa Lurye, senior director of product and head of women’s health at Hinge Health

Hinge Health is a digital clinic for joint and muscle pain on a mission to reduce musculoskeletal pain, opioid use and surgeries by pairing advanced wearable technology with a comprehensive clinical care team.

Sylvia Kang, founder and CEO of Mira 

Mira is a San Francisco-based health start-up providing integrative care and hormonal testing. The company aims to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives.

Dr Jennifer Hintzsche, founder and CEO of PherDal Fertility

PherDal is developing the first FDA-cleared, at-home fertility treatment. Its technology aims to bring assisted reproduction back into the home as an affordable, over-the-counter fertility treatment.

Athena Doshi, founder and CEO of Celeste

Celeste is a start-up which uses AI-powered precision medicine to enable healthcare providers and payers to assess how a patient will respond to medications and subsequently create personalised adherence plans.

Continue Reading

Femtech World Awards

Femtech World reveals Fertility Innovation shortlist



Six fertility innovators have made the shortlist for Femtech World’s Fertility Innovation award sponsored by Apryl. Check them out below.  

Apryl is a fertility benefits platform that helps employers attract and retain top talent while tackling diversity and inclusion.

The company helps employers support their employees with fertility and family planning benefits, including consultation, access to clinics, treatments and adoption.

Through the Fertility Innovation Award, sponsored by Apryl, Femtech World aims to shine a light on the life-changing work of those developing innovative fertility solutions.

The six finalists will now go-head-to-head, with the winner announced at a virtual ceremony on May 2.


Selectivity is a start-up focused on universalising access to fertility treatments. The company is working towards developing better, accessible and cost-saving assisted reproductive devices that are promising to transform the patient journey to conception. 

Future Fertility is the first company in the world to address this significant gap in treatment planning and patient expectation management by developing AI-powered oocyte assessment software that provides patients and their fertility care teams with personalised egg quality insights.

The software uses deep learning technology to analyse 2D images of mature oocytes, providing egg quality scores that have been validated in laboratories and clinical practice and are proven to correlate directly with reproductive outcomes.

Proov is a diagnostics company offering medical grade at-home tests and a support platform that is clinically proven to help those looking to conceive do so faster and more cost-effectively.

Proov founder, Dr Amy Beckley, PhD, created the core Proov technology after her own battle with infertility. The company now boasts over 10 products and continues to innovate to bring additional solutions to child bearing people and their partners.

Fairtility is advancing reproductive care through the power of transparent AI to help clinicians and their patients on the reproductive care journey.

The company believes that transparency is critical when AI intersects with human life. Its flagship software, CHLOE, is a transparent AI-based decision support tool providing clinicians with visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation and egg donation.

Embie aims to optimise fertility treatments with personalised, connected care. The Embie Clinic platform seeks to empower clinics with real-time, data driven insights, while reducing the administrative and cognitive load for the clinic.

Plan Your Baby is a telehealth fertility clinic on a mission to reduce practical and financial barriers to IVF.

The platform leverages cutting-edge technology to provide support from preconception to birth, while addressing 13 of the main treatable causes of infertility.

Continue Reading

Femtech World Awards

Seven start-ups to go head-to-head at Femtech World Awards



Seven femtech start-ups have made the shortlist for Femtech World’s OB/GYN Innovation award sponsored by Cross-Border Impact Ventures

CrossBorder Impact Ventures is on a mission to revolutionise venture capital investing in health technology. The company invests in early-growth stage health technology companies commercialising medical devices, diagnostics, therapeutics and digital health innovations and leveraging cutting-edge technologies like AI and machine learning.

All financed innovations are relevant to women, children and adolescent health and located in North America, Europe and Israel with ability to scale technologies to Emerging Markets.

The shortlisted companies in the OB/GYN Innovation category stood out among some truly remarkable entries from all over the world.

The seven shortlisted entries will soon be judged by the category sponsor, with the ultimate winner announced at a virtual event on May 2.


Nesa Medtech is a a medical device start-up on a mission to transform women’s health by developing minimally invasive surgical solutions.

The company’s flagship product is a novel, minimally invasive and uterus-preserving technology aimed at treating uterine fibroids, a condition which has profound impacts on healthcare delivery and costs worldwide.

EndoCure aims to revolutionise the diagnosis of endometriosis with a novel robotic AI-powered ultrasound. The system is specifically designed to detect endometriosis lesions, which currently can’t be detected by imaging tools.

The ability to detect such lesions, EndoCure says, is crucial as the pain associated with endometriosis can be excruciating and life-altering. This capability not only promises to shorten the diagnostic journey for millions of women suffering from endometriosis but also aims to enhance the accuracy of diagnosis.

Hale offers a virtual-first care model that aims to reshape patient journeys for gynaecological conditions.

The platform leverages cutting-edge technology and interdisciplinary expertise to provide comprehensive care solutions, including online consultations, care navigation support, digital prescriptions and diagnostic fast-tracking processes.


Lasa Health is a health tech company supporting the diagnosis and management of pelvic pain disorders. The company uses AI and machine learning to screen patients for the potential causes of chronic pelvic pain.

Its algorithm, according to its developers, is able to catch conditions that would have otherwise been missed by physicians. The platform provides personalised recommendations for physicians to review and discuss with patients. 

Sonio is an AI solution for prenatal screening and diagnosis with over five years of research and collaborations between leading experts in foetal medicine and AI.

Sonio’s goal is to support foetal ultrasound practitioners in prenatal screening and diagnosis by assuring the completeness of their examination and increasing the accuracy of their patient scan results.

Based in Switzerland, Aspivix is a medical device company on a mission to reimagine and modernise gynaecology.

Its flagship product, Carevix, is the world’s first suction cervical stabiliser clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynaecology, including IUD insertion, hysteroscopy, cervical biopsies and fertility treatments.

Yeda is developing a sustainable device that aims to support women’s pelvic floor and improve bladder control. The company is committed to improving women’s quality of life by offering personalised and user-friendly treatment.

Its device promises to disrupt the market by reducing hospital visits and providing gynaecologists with an innovative tool for their patients.

Continue Reading


Copyright © 2023 Aspect Publishing Ltd. All Rights Reserved.